BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32448296)

  • 1. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
    Franceschini D; Cozzi L; Loi M; Franzese C; Reggiori G; Mancosu P; Clivio A; Fogliata A; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2267-2276. PubMed ID: 32514629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
    Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
    Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
    Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
    J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study.
    De Rose F; Cozzi L; Meattini I; Fogliata A; Franceschini D; Franzese C; Tomatis S; Becherini C; Livi L; Scorsetti M
    Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):26-34. PubMed ID: 31377082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
    van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
    Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
    [No Abstract]   [Full Text] [Related]  

  • 9. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
    Karpf D; Sakka M; Metzger M; Grabenbauer GG
    Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
    Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
    J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer.
    Barsky AR; George J; Wroe AJ; Mittauer KE; Kaiser A; Herrera R; Yu J; Gutierrez AN; Alvarez D; McCulloch J; Kasper ME; Mehta MP; Chuong MD
    Med Dosim; 2024 Summer; 49(2):121-126. PubMed ID: 38001010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
    Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
    Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
    De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
    Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
    Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
    Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Multi-Criteria Optimization-based Trade-Off exploration in combination with RapidPlan for head & neck radiotherapy planning.
    Miguel-Chumacero E; Currie G; Johnston A; Currie S
    Radiat Oncol; 2018 Nov; 13(1):229. PubMed ID: 30470254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
    Chi A; Lin LC; Wen S; Yan H; Hsi WC
    Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
    Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
    Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
    Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
    Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer.
    Anakotta RM; van der Laan HP; Visser S; Ribeiro CO; Dieters M; Langendijk JA; Both S; Korevaar EW; Sijtsema NM; Knopf A; Muijs CT
    Radiother Oncol; 2020 Oct; 151():66-72. PubMed ID: 32663538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.